After more than three decades of not finding new drugs to treat melanoma, British laboratories have devised two new drugs to treat this tumor: Dabrafenib and Trametinib.
Melanoma
According to British scientists, Trametinib can neutralize a protein called MEK that stimulates the growth of melanoma while Dabrafenib can prevent a mutant gene called BRAF to produce a Protein promotes the growth of this tumor.
According to the scientists, in people treated with trametinib, melanoma did not develop in 4.8 months, ie a 55% reduction in development risk compared to 1 and a half months in those receiving the treatment chemotherapy.
Meanwhile, Dabrafenib treatment also showed a 70% reduction in the risk of melanoma in 5.1 months compared to those treated with classical chemotherapy.
